Page last updated: 2024-11-07

indenestrol b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Indenestrol b is a non-steroidal synthetic estrogen. It was first synthesized in 1951 and was initially marketed as a treatment for menopausal symptoms. However, it was withdrawn from the market due to concerns about its safety. Indenestrol b has been shown to have estrogenic activity in animal studies, but its effects in humans are not well understood. The compound is currently being studied for its potential therapeutic uses, such as in the treatment of breast cancer. It is being investigated for its potential as a selective estrogen receptor modulator (SERM). SERMs are a class of drugs that can act as agonists or antagonists of estrogen receptors, depending on the target tissue. Indenestrol b is also being studied for its potential to prevent osteoporosis.'

Cross-References

ID SourceID
PubMed CID114716
MeSH IDM0137158

Synonyms (15)

Synonym
indenestrol b
1h-inden-5-ol, 1-ethyl-2-(4-hydroxyphenyl)-3-methyl-
ccris 7205
1-ethyl-2-(4-hydroxyphenyl)-3-methyl-1h-inden-5-ol
indenoestrol b
38028-27-2
133830-97-4
unii-jhx6qh0hf6
jhx6qh0hf6 ,
(+/-)-indenestrol b
indenestrol b, (+/-)-
(rs)-indenestrol b
1-ethyl-2-(4-hydroxyphenyl)-3-methylinden-5-ol
Q27281510
DTXSID301030716
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's4 (66.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.05 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]